Biophta is currently owned by Elaia Partners, through DTS3, since 2024.

When did Elaia Partners acquire Biophta?

Elaia Partners acquired Biophta in 2024 (active for 2 years).

Home/Companies/Biotech/Biophta

Biophta

Biotech·

France·Active·2yr hold

Biophta is a biotechnology company, headquartered in France.

Entry

2024

Hold

2yr

Status

Active

Est. EV

–

Investor

Elaia Partners

Key facts

HQFrance

SectorBiotechnology

BIOPHTA aims to radically improve the efficacy of eye treatments by leveraging the first 7-day continuous microdosing pharmaceutical form.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from DTS3

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings